NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Sponsor: University Hospital, Lille
Conditions: Parkinson's Disease
Interventions: patients with Parkinson's disease
Countries: France
This study identify preoperative predictors of response to subthalamic stimulation at 1 year, 3 years and 5 years in terms of quality of life, from a broad prospective multicenter study French with standardized collection of clinical data , imaging and genetic . The investigators want to identify factors that predict the improvement of quality of life for one year corresponding to a decrease of PDQ39 score of at least 20 %. They believe that improvement would be less likely to become zero to 3 or 5 years and question the indication of the subthalamic stimulation (risks and costs). This is part of a process of "personalization" of the therapeutic care that is of any interest to the subthalamic stimulation. It is a therapeutic option that could be dangerous if patient selection is not optimal , and expensive, if the benefit is not large enough to reduce the number of medications and hospitalizations medium term . In addition, it will quantify the improvement of quality of life in the longer term and harmonize national assessments .
Sex: ALL
Age: 18 Years to 75 Years
Healthy volunteers: No
Study type: OBSERVATIONAL
Inclusion Criteria: * Patients receiving a pre- therapeutic assessment and therapeutic monitoring for one year , 3 years and 5 years as part of the regular monitoring of the subthalamic stimulation * Bilateral STN stimulation considered * Patient able to provide their free and informed consent * Patient with insurance coverage Exclusion Criteria: * Atypical Parkinson's disease do not meet the criteria of stuff . * MP under 5 years * Severe cognitive impairment or dementia ( Score Moca \<24 and DSM-IV criteria) * Parkinson's Psychosis * Reply to L- dopa \<30 % * Against indication for surgery * Severe brain atrophy or abnormal MRI * The presence of another very serious condition terminal life- short-term prognosis ( malignancy ) is an indication against .
- Amiens, France
- Bron, France
- Clermont-Ferrand, France
- Lille, France
- Marseille, France
- Nancy, France
- Nantes, France
- Nice, France
- Paris, France
- Paris, France
- Poitiers, France
- Rennes, France
- Rouen, France
- Strasbourg, France
- Toulouse, France